title: Glucocorticoids in autoimmune bullous diseases: are neutrophils the key cellular target?
abstract: The newly observed nongenomic effects of glucocorticoids on signaling pathways operating in neutrophils in vitro will stimulate further investigations on pathogenic mechanisms and drug actions in bullous skin diseases.
authors.affiliation: Department of Dermatology, University Hospital Bern, Inselspital, Bern, Switzerland. Electronic address: hus@pki.unibe.ch.
authors.forename: Dagmar
authors.initials: D
authors.lastname: Simon
authors.affiliation: Department of Dermatology, University Hospital Bern, Inselspital, Bern, Switzerland.
authors.forename: Luca
authors.initials: L
authors.lastname: Borradori
authors.affiliation: Institute of Pharmacology, University of Bern, Bern, Switzerland.
authors.forename: Hans-Uwe
authors.initials: HU
authors.lastname: Simon
mesh_terms: D000818:Animals; D001323:Autoantibodies / Q000276:immunology*; D016107:Epidermolysis Bullosa Acquisita / Q000188:drug therapy*; D006801:Humans; D008775:Methylprednisolone / Q000494:pharmacology*; D009504:Neutrophils / Q000187:drug effects*; D010391:Pemphigoid, Bullous / Q000188:drug therapy*
chemical_list: D001323:Autoantibodies; D008775:Methylprednisolone